RAKSHIT DRUGS PVT LTD

Overview

RAKSHIT DRUGS PVT LTD is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering ACETYL DAPAGLIFLOZIN / TETRA ACETYL DAPAGLIFLOZIN; APIXABAN; DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE; LEFLUNOMIDE; MIRABEGRON.

API / Drug Master Files

RAKSHIT DRUGS PVT LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LEFLUNOMIDEActive2026-02-09
• MIRABEGRONActive2025-07-03
• APIXABANActive2025-05-26
• DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATEActive2025-05-24
• ACETYL DAPAGLIFLOZIN / TETRA ACETYL DAPAGLIFLOZINActive2025-01-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to RAKSHIT DRUGS PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.